Vanguard Group’s IN8bio INAB Stock Holding History

Vanguard Group’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$66.3K	Sell	28,348 -31,070	-52%	-$59.1K	﹤0.01%	4211
2025 Q3	$129K	Sell	59,418 -679	-1%	-$1.49K	﹤0.01%	4191
2025 Q2	$126K	Sell	60,097 -2	-0%	-$8	﹤0.01%	4129
2025 Q1	$299K	Buy	60,099 +12,636	+27%	+$101K	﹤0.01%	3992
2024 Q4	$366K	Hold	47,463	–	–	﹤0.01%	4014
2024 Q3	$384K	Hold	47,463	–	–	﹤0.01%	4034
2024 Q2	$1.21M	Hold	47,463	–	–	﹤0.01%	3728
2024 Q1	$1.68M	Buy	47,463 +33,573	+242%	+$1.27M	﹤0.01%	3646
2023 Q4	$575K	Buy	13,890 +2,599	+23%	+$83.1K	﹤0.01%	3990
2023 Q3	$352K	Buy	11,291 +1,705	+18%	+$64K	﹤0.01%	4153
2023 Q2	$443K	Buy	9,586 +2,584	+37%	+$162K	﹤0.01%	4152
2023 Q1	$273K	Buy	7,002 +1,380	+25%	+$77K	﹤0.01%	4271
2022 Q4	$390K	Sell	5,622 -29	-0.5%	-$1.62K	﹤0.01%	4165
2022 Q3	$342K	Buy	5,651 +1,961	+53%	+$132K	﹤0.01%	4314
2022 Q2	$250K	Sell	3,690 -26	-0.7%	-$2.2K	﹤0.01%	4439
2022 Q1	$372K	Sell	3,716 -291	-7%	-$32.6K	﹤0.01%	4442
2021 Q4	$528K	Buy	4,007 +237	+6%	+$46.8K	﹤0.01%	4424
2021 Q3	$775K	Buy	+3,770	New	+$937K	﹤0.01%	4299

Other funds holding INAB

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TCBWMS

Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Vanguard Group's INAB Position: Q4 2025 in Review

Vanguard Group reduced its IN8bio (INAB) stake by 52% in Q4 2025, selling an estimated $59.1K and leaving 28,348 shares worth $66.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4211.

Vanguard Group first reported a position in INAB in Q3 2021 and has held it in 18 quarters since. The position peaked at $1.68M in Q1 2024. 22 funds tracked by Wall St. Rank hold INAB as of Q4 2025.

Vanguard Group held 28,348 shares of IN8bio worth $66.3K as of Q4 2025.
Vanguard Group sold 31,070 IN8bio shares in Q4 2025, an estimated $59.1K.
IN8bio made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4211 holding.
Vanguard Group first reported a position in IN8bio in Q3 2021 and has held it in 18 quarters since.
Vanguard Group's IN8bio position peaked at $1.68M in Q1 2024.
22 funds tracked by Wall St. Rank held IN8bio as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.